|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Executive Committee: InterMune Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
Company details: InterMune Inc
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +7.20% | -5.65% | +1.02% | 46.2B | |
| +2.19% | +11.71% | +393.31% | +580.42% | 38.71B | |
| +2.53% | +13.93% | +21.38% | -12.81% | 31.9B | |
| +1.65% | +3.61% | +16.04% | +55.62% | 31.12B | |
| -4.16% | -2.58% | +8.94% | +25.31% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +69.64% | +130.07% | 15.05B | |
| +1.00% | +10.30% | +13.31% | +20.31% | 13.74B | |
| +3.63% | +9.53% | +103.97% | +98.73% | 13.42B | |
| Average | +0.82% | +9.14% | +77.62% | +112.33% | 25.57B | |
| Weighted average by Cap. | +0.75% | +8.71% | +88.75% | +130.90% |
- Stock Market
- Stocks
- Stock
- Company InterMune Inc
Select your edition
All financial news and data tailored to specific country editions
